Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLA2 - Newly diagnosed and chronic pediatric immune thrombocytopenia: peripheral blood T-cells
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLA2 - Type 2 diabetic obese patients: visceral adipose tissue CD14+ cells
SLA2 - Atherosclerotic Coronary Artery Disease: circulating mononuclear cell types
SLA2 - Recombinant Interferon α effect on natural killer cells in vitro
SLA2 - Natural killer cell response to interleukin-2 treatment: time course
SLA2 - Host cell response to HIV-1 Vpr-induced cell cycle arrest: time course
SLA2 - Metastatic melanoma: peripheral blood lymphocytes
SLA2 - Cyclin-dependent kinase inhibitor R547 effect on peripheral blood mononuclear cells: dose response and time course
SLA2 - Interleukin-12 effect on peripheral blood mononuclear cells (HG-U133B)
SLA2 - Pancreatic ductal adenocarcinoma surgery patients: circulating tumor cells
SLA2 - Recurrent squamous cell carcinoma of the lung: primary tumor
GEO DataSets Gene Chromosome neighbors Homologene neighbors
SLA2 - Hypoxia-inducible factors-1 and -2 overexpression effect on embryonic kidney cells
SLA2 - Acute myeloid leukemia cell lines with high Ecotropic Viral Integration site 1 expression
SLA2 - Staphylococcal superantigen toxins effect on peripheral blood mononuclear cells
SLA2 - NF-kB inactivation effect on T-ALL1 cell lines
SLA2 - Subcutaneous Interferon-beta-1b treatment in relapsing-remitting multiple sclerosis (U133 B): peripheral mononuclear blood cells
SLA2 - Inhibition of Notch signaling in T cell acute lymphoblastic leukemia cell lines
SLA2 - Identical twins discordant for Multiple sclerosis: CD4+ and CD8+ T cells
SLA2 - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
SLA2 - WHO 2008-classified acute myeloid leukemia subgroups (Analysis I): bone marrow mononuclear cells
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on